Increased Plasma Levels of Adenylate Cyclase 8 and cAMP Are Associated with Obesity and Type 2 Diabetes: Results from a Cross-Sectional Study.

• 影响指数: 5.168
• 发表时间: Aug 2020 24
• 来源期刊: Biology (Basel)
• DOI: 10.3390/biology9090244
• PMID: 32847122
• 文章类型: Journal Article
• 作者列表: Abdel-Halim SM,Al Madhoun A,Nizam R,Melhem M,Cherian P,Al-Khairi I,Haddad D,Abu-Farha M,Abubaker J,Bitar MS,Al-Mulla F

关键词: ADCY1; ADCY3; ADCY8; Type 2 diabetes; adenylate cyclase 8; cAMP; obesity

Abstract

Adenylate cyclases (ADCYs) catalyze the conversion of ATP to cAMP, an important co-factor in energy homeostasis. Giving ADCYs role in obesity, diabetes and inflammation, we questioned whether calcium-stimulated ADCY isoforms may be variably detectable in human plasma. We report the results of a cross-sectional study assessing circulating levels of functional ADCY1, -3 and -8 in patients with T2D vs. non-diabetic (ND) controls in association with obesity. ADCY1 levels exhibited no significant change between ND and T2D groups. ADCY3 levels were lower in obese individuals, albeit not statistically significantly. In contrast, ADCY8 plasma levels were significantly higher in obese and T2D patients compared to controls (p = 0.001) and patients with T2D only (p = 0.039). ADCY8 levels correlated positively with body mass index and Hb1Ac levels. Parallel to the increased ADCY8 levels, significantly higher cAMP levels were observed in patients with T2D compared with ND controls, and further elevated in obese individuals, irrespective of T2D status. Additionally, cAMP levels positively correlated with fasting plasma glucose levels. In conclusion, the current cross-sectional study demonstrated elevated levels of circulating plasma ADCY8 and cAMP in obesity and T2D.